Cross-border converter
NAF rév. 2.1 21.10 → DB07 equivalent (Denmark)
France's national activity classification (NAF rév. 2.1) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent DB07 subclass(es) used in Denmark.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21.10
Fabrication de produits pharmaceutiques de base
211000
Fremstilling af farmaceutiske råvarer
Branchen omfatter fremstilling af farmaceutiske råvarer til brug i fx lægemidler. Branchen omfatter også forarbejdning af blod, fremstilling af kemisk rent sukker og forarbejdning af kirtler.
About this conversion
NAF rév. 2.1 is the activity classification used in France. DB07 is the equivalent system in Denmark. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "NAF rév. 2.1 21.10 to DB07" and stays in sync with our monthly Market Intelligence sync.